Top News
Latest News
MARKET TRENDS
19 Mar 2026
A Vaccine Tailored to You? Birmingham Tests ItINSIGHTS
16 Mar 2026
Europe Ranks Third in Global mRNA RacePARTNERSHIPS
10 Mar 2026
Can mRNA Conquer TB and Malaria? Germany Is TryingINNOVATION
20 Feb 2026
The Next mRNA Breakthrough May Be in the Packaging
mRNA Makers Face a More Exacting Europe
REGULATORY
12 Feb 2026
Draft guidance signals tougher standards for mRNA vaccines and a shift toward long-term regulatory rigor
MARKET TRENDS
19 Mar 2026
A Vaccine Tailored to You? Birmingham Tests It
UK hospital leads Europe’s first personalised mRNA trial for pancreatic cancer, aiming to stop relapse after surgery
INSIGHTS
16 Mar 2026
Europe Ranks Third in Global mRNA Race
A new study of 557 trials shows Europe is a primary hub for mRNA innovation as the field pivots from COVID-19 to oncology and rare disease...
PARTNERSHIPS
10 Mar 2026
Can mRNA Conquer TB and Malaria? Germany Is Trying
Ethris and DZIF partner to develop next-gen mRNA vaccines for TB, malaria, hepatitis and more using advanced LNP platforms
INNOVATION
20 Feb 2026
The Next mRNA Breakthrough May Be in the Packaging
Early NeoVac data hint that redesigned lipid nanoparticles could make mRNA vaccines safer for repeat use
REGULATORY
12 Feb 2026
mRNA Makers Face a More Exacting Europe
Draft guidance signals tougher standards for mRNA vaccines and a shift toward long-term regulatory rigor
INNOVATION
6 Feb 2026
From Concept to Clinic, Circular RNA Faces Its Test
A December 2025 deal between Circurna and uBriGene highlights how circular RNA is shifting from promise to production
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.